- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04104841
School-Based Depression Prevention for Adolescents With ADHD (BEAMS)
December 20, 2023 updated by: University of Maryland, College Park
The purpose of this study is to develop a modified behavioral activation program in adolescents with ADHD to be implemented by school mental health providers in an urban, low-income school district.
Subsequently the investigators will examine its effectiveness in reducing depressive symptoms and improving emotion regulation and reward responsivity, compared to usual care.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Children with ADHD are at elevated risk for depression in adolescence and young adulthood, and this comorbidity is associated with far greater impairment than either disorder alone, including higher rates of inpatient hospitalization and increased risk for suicidal ideation and behavior.
Despite these adverse outcomes, existing evidence-based interventions for ADHD have not demonstrated effects in reducing depressive symptoms nor do established depression prevention programs work as well for adolescents with ADHD.
Reward responsivity (RR) and emotion regulation (ER) are two key factors demonstrated to mediate the association between ADHD and depression and are thus key targets for prevention.
In an effort to address the gap between access and utilization of mental health care, which is especially stark among adolescents with ADHD, the investigators aim to develop and test a modified behavioral activation prevention program [Behaviorally Enhancing Adolescents' Mood in Schools (BEAM-S)] that incorporates modules to directly target these purported mechanisms.
In line with the Deployment-Focused Model of Intervention Development and Testing, the investigators will develop a program that can be easily implemented and sustainable in the high school setting as delivered by school mental health staff that reduces depression and improves overall functioning in adolescents with ADHD, by way of improving RR and ER.
As a first step, the investigators will conduct focus groups with community stakeholders (e.g., school mental health providers, school administration, adolescents, parents, teachers) to develop an acceptable and sustainable selected and indicated prevention program for school staff to utilize.
The investigators will then initially train school staff to deliver this prevention program via to pilot the intervention for implementation of the prevention program in a case series to evaluate preliminary feasibility.
The investigators will then conduct a stage 1 RCT with a hybrid-type 1 implementation effectiveness design in three high schools where adolescents will be randomized to either the BEAM-S condition (n= 54) or treatment as usual (n = 54).
Finally, qualitative and quantitative data from aims 1-3 will be used to prepare final procedures for a future large-scale effectiveness trial R01 (aim 4).
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
College Park, Maryland, United States, 20742
- University of Maryland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Enrolled in a participating Baltimore City Public High School
- DSM-5 Diagnosis of attention-deficit/hyperactivity disorder (ADHD)
- Depressive symptoms above T=65 on the Children's Depression Inventory (CDI)
Exclusion Criteria:
- History of seizures or neurological problems
- DSM-diagnosis of Pervasive Developmental Disorder
- Full scale IQ below 70
- Current depressive symptoms or active suicidality at severe levels where more intensive services would be warranted
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behaviorally Enhancing Adolescents' Mood in Schools (BEAMS)
8-session modified behavioral activation program
|
8-session modified behavioral activation intervention
|
|
Active Comparator: Usual Care
Referrals to usual care
|
Referral to school mental health provider, social worker, or community care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: After the 8-week preventive intervention
|
Adolescent and parent reported depressive symptoms
|
After the 8-week preventive intervention
|
|
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: 4-week follow-up
|
Adolescent and parent reported depressive symptoms
|
4-week follow-up
|
|
Children's Depression Inventory, 2nd Edition (CDI-2)
Time Frame: 12-week follow-up
|
Adolescent and parent reported depressive symptoms
|
12-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Affective Reactivity Index
Time Frame: After the 8-week preventive intervention
|
Adolescent and parent reported irritability
|
After the 8-week preventive intervention
|
|
Affective Reactivity Index
Time Frame: 4-week follow-up
|
Adolescent and parent reported irritability
|
4-week follow-up
|
|
Affective Reactivity Index
Time Frame: 12-week follow-up
|
Adolescent and parent reported irritability
|
12-week follow-up
|
|
Suicide Behavior Questionnaire
Time Frame: After the 8-week preventive intervention
|
Adolescent reported suicidal thoughts and behaviors
|
After the 8-week preventive intervention
|
|
Suicide Behavior Questionnaire
Time Frame: 4-week follow-up
|
Adolescent reported suicidal thoughts and behaviors
|
4-week follow-up
|
|
Suicide Behavior Questionnaire
Time Frame: 12-week follow-up
|
Adolescent reported suicidal thoughts and behaviors
|
12-week follow-up
|
|
Emotion Regulation Checklist
Time Frame: After the 8-week preventive intervention
|
Parent reported emotion dysregulation
|
After the 8-week preventive intervention
|
|
Emotion Regulation Checklist
Time Frame: 4-week follow-up
|
Parent reported emotion dysregulation
|
4-week follow-up
|
|
Emotion Regulation Checklist
Time Frame: 12-week follow-up
|
Parent reported emotion dysregulation
|
12-week follow-up
|
|
Difficulties in Emotion Regulation
Time Frame: After the 8-week preventive intervention
|
Adolescent reported emotion dysregulation
|
After the 8-week preventive intervention
|
|
Difficulties in Emotion Regulation
Time Frame: 4-week follow-up
|
Adolescent reported emotion dysregulation
|
4-week follow-up
|
|
Difficulties in Emotion Regulation
Time Frame: 12-week follow-up
|
Adolescent reported emotion dysregulation
|
12-week follow-up
|
|
Mirror Tracing Persistence Task
Time Frame: After the 8-week preventive intervention
|
Emotion regulation behavioral task
|
After the 8-week preventive intervention
|
|
Mirror Tracing Persistence Task
Time Frame: 4-week follow-up
|
Emotion regulation behavioral task
|
4-week follow-up
|
|
Mirror Tracing Persistence Task
Time Frame: 12-week follow-up
|
Emotion regulation behavioral task
|
12-week follow-up
|
|
Tripartite Pleasure Inventory
Time Frame: After the 8-week preventive intervention
|
Adolescent reported reward responsiveness
|
After the 8-week preventive intervention
|
|
Tripartite Pleasure Inventory
Time Frame: 4-week follow-up
|
Adolescent reported reward responsiveness
|
4-week follow-up
|
|
Tripartite Pleasure Inventory
Time Frame: 12-week follow-up
|
Adolescent reported reward responsiveness
|
12-week follow-up
|
|
Reward Probability Index
Time Frame: After the 8-week preventive intervention
|
Measure of adolescent reported environmental reward
|
After the 8-week preventive intervention
|
|
Reward Probability Index
Time Frame: 4-week follow-up
|
Measure of adolescent reported environmental reward
|
4-week follow-up
|
|
Reward Probability Index
Time Frame: 12-week follow-up
|
Measure of adolescent reported environmental reward
|
12-week follow-up
|
|
Behavioral Activation for Depression Scale
Time Frame: After the 8-week preventive intervention
|
Adolescent reported measure of behavioral activation and avoidance
|
After the 8-week preventive intervention
|
|
Behavioral Activation for Depression Scale
Time Frame: 4-week follow-up
|
Adolescent reported measure of behavioral activation and avoidance
|
4-week follow-up
|
|
Behavioral Activation for Depression Scale
Time Frame: 12-week follow-up
|
Adolescent reported measure of behavioral activation and avoidance
|
12-week follow-up
|
|
Balloon Analog Risk Task
Time Frame: After the 8-week preventive intervention
|
Positive reinforcement
|
After the 8-week preventive intervention
|
|
Balloon Analog Risk Task
Time Frame: 4-week follow-up
|
Positive reinforcement
|
4-week follow-up
|
|
Balloon Analog Risk Task
Time Frame: 12-week follow-up
|
Positive reinforcement
|
12-week follow-up
|
|
Impairment Rating Scale
Time Frame: After the 8-week preventive intervention
|
Parent- and teacher- report of global impairment
|
After the 8-week preventive intervention
|
|
Impairment Rating Scale
Time Frame: 4-week follow-up
|
Parent- and teacher- report of global impairment
|
4-week follow-up
|
|
Impairment Rating Scale
Time Frame: 12-week follow-up
|
Parent- and teacher- report of global impairment
|
12-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Michael Meinzer, PhD, University of Maryland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 7, 2018
Primary Completion (Actual)
July 1, 2021
Study Completion (Actual)
July 11, 2022
Study Registration Dates
First Submitted
September 24, 2019
First Submitted That Met QC Criteria
September 24, 2019
First Posted (Actual)
September 26, 2019
Study Record Updates
Last Update Posted (Actual)
December 27, 2023
Last Update Submitted That Met QC Criteria
December 20, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH117086
- R34MH117086 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Mental Health Services in the Capital Region, DenmarkHospital del Mar Research Institute (IMIM); Research Centre of the German Foundation... and other collaboratorsEnrolling by invitationDepression - Major Depressive Disorder | Mental DistressSpain, Germany, Denmark
-
Medical Research CouncilKU LeuvenCompletedDepressive Symptoms | Major Depressive DisorderAustralia
-
Massachusetts General HospitalCompletedMajor Depressive DisorderUnited States, China
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada